Radio and PodcastRadio and PodcastLive Radio & Podcasts
E121: Obinutuzumab in SLE-LN artwork
Health

E121: Obinutuzumab in SLE-LN

The Evidence Based Rheumatology Podcast by Michael Putman

Apr 2, 202518:14Health

Another day, another b cell podcast. Seems to be all the rage! This week I discuss the recently published NEJM trial of the anti CD20 agent obinutuzumab in lupus nephritis. Worth a read and listen, paper can be found her...

Related Episodes

Continue listening to more episodes from The Evidence Based Rheumatology Podcast.

E135: IL17 and a GLP1?

Apr 30, 2026 - 11:03

Really interesting study this week comparing the IL17 inhibitor ixekizumab WITH the GLP1 inhibitor tirzep...